Last updated 2026-06-18
- Raised $16.5M funding round led by ALIVE Israel Healthtech Fund, Feb 2024
- Raised $1.7M funding round led by The Trendlines Group, Mar 2020
Total raised
$18.2M
Last: 2024-02
Stage
Series A
Founded
2015
Headcount
9
HQ
Israel
Sector
Health Tech & Life Sciences
About
Vessi Medical is developing a new approach in the treatment of urological tissue. The company treats superficial urological tissue using surface cryotherapy, utilizing extreme cold to freeze and destroy abnormal tissue.
The Vessi Medical system consists of a stand-alone console and a disposable catheter which is inserted into the bladder in a manner similar to existing intravesical techniques. Vessi's minimally invasive unique cryotherapy solution provides a therapeutic alternative to surgery while reducing the cost and complications associated with current treatments.
First in human study (FIH) clinical trial was finalized (2023) , with very promising results.
Funding history · 2 rounds · $18.2M total
Q&A
- What is Vessi Medical's primary focus?
- Vessi Medical is developing a new approach to treating urological tissue, specifically using surface cryotherapy to freeze and destroy abnormal tissue.
- When was Vessi Medical founded?
- Vessi Medical was founded in June 2015.
- What is the current employee count for Vessi Medical?
- Vessi Medical has 1-10 employees.
- What was Vessi Medical's most recent funding round?
- In February 2024, Vessi Medical raised $16,500,000. The round was led by ALIVE Israel Healthtech Fund.
- What is Vessi Medical's total funding to date?
- Vessi Medical has raised a total of $18,200,000 across its funding rounds.
- What is the status of Vessi Medical's clinical trials?
- Vessi Medical finalized its first-in-human (FIH) clinical trial in 2023, reporting very promising results.
- Who is the founder and CEO of Vessi Medical?
- Eyal Kochavi is the Founder & CEO of Vessi Medical.
- What is the core technology behind Vessi Medical's system?
- Vessi Medical's system utilizes a stand-alone console and a disposable catheter for minimally invasive surface cryotherapy, providing an alternative to surgery for superficial urological tissue.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
catheterstargeted-therapyurologyhospitalsoncologycancermedical-devicesdoctorstreatmentsmedical-technologiesminimally-invasive
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | vessimed.com |
|---|---|
| linkedin.com/company/18776827 |
Identifiers & details
| Founded | 2015-6 |
|---|---|
| Employees (exact) | 9 |
Radar intelligence
Patents
| EPO | 4 |
|---|
Web history (Wayback)
| Domain | vessimed.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|